These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 17406276)

  • 1. Rational design and in vitro and in vivo delivery of Dicer substrate siRNA.
    Amarzguioui M; Lundberg P; Cantin E; Hagstrom J; Behlke MA; Rossi JJ
    Nat Protoc; 2006; 1(2):508-17. PubMed ID: 17406276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Principles of Dicer substrate (D-siRNA) design and function.
    Amarzguioui M; Rossi JJ
    Methods Mol Biol; 2008; 442():3-10. PubMed ID: 18369774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing.
    Myers JW; Jones JT; Meyer T; Ferrell JE
    Nat Biotechnol; 2003 Mar; 21(3):324-8. PubMed ID: 12592410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of microarrays in transfection of mammalian cells with dicer-digested small interfering RNAs.
    Fujimoto H; Kato K; Iwata H
    Anal Biochem; 2008 Mar; 374(2):417-22. PubMed ID: 18201542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DICER-LIKE 4 is required for RNA interference and produces the 21-nucleotide small interfering RNA component of the plant cell-to-cell silencing signal.
    Dunoyer P; Himber C; Voinnet O
    Nat Genet; 2005 Dec; 37(12):1356-60. PubMed ID: 16273107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dicer efficiently converts large dsRNAs into siRNAs suitable for COX-2 gene].
    Luo H; Hu DX; Chen P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):437-42. PubMed ID: 17611321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy.
    Kim DH; Behlke MA; Rose SD; Chang MS; Choi S; Rossi JJ
    Nat Biotechnol; 2005 Feb; 23(2):222-6. PubMed ID: 15619617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Dicer enhances RNAi-mediated gene silencing by short-hairpin RNAs (shRNAs) in human cells.
    Mikuma T; Kawasaki H; Yamamoto Y; Taira K
    Nucleic Acids Symp Ser (Oxf); 2004; (48):191-2. PubMed ID: 17150543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. siRNA produced by recombinant dicer mediates efficient gene silencing in islet cells.
    Hägerkvist R; Mokhtari D; Myers JW; Tengholm A; Welsh N
    Ann N Y Acad Sci; 2005 Apr; 1040():114-22. PubMed ID: 15891014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells.
    Lee NS; Dohjima T; Bauer G; Li H; Li MJ; Ehsani A; Salvaterra P; Rossi J
    Nat Biotechnol; 2002 May; 20(5):500-5. PubMed ID: 11981565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
    Bartlett DW; Davis ME
    Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of RNA interference by adenovirus virus-associated RNA.
    Andersson MG; Haasnoot PC; Xu N; Berenjian S; Berkhout B; Akusjärvi G
    J Virol; 2005 Aug; 79(15):9556-65. PubMed ID: 16014917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local RNA target structure influences siRNA efficacy: a systematic global analysis.
    Overhoff M; Alken M; Far RK; Lemaitre M; Lebleu B; Sczakiel G; Robbins I
    J Mol Biol; 2005 May; 348(4):871-81. PubMed ID: 15843019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for targeting common siRNA hotspots and GC preference by plant Dicer-like proteins.
    Ho T; Wang H; Pallett D; Dalmay T
    FEBS Lett; 2007 Jul; 581(17):3267-72. PubMed ID: 17597620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of human T-cell lymphotropic virus type I Rex protein with Dicer suppresses RNAi silencing.
    Abe M; Suzuki H; Nishitsuji H; Shida H; Takaku H
    FEBS Lett; 2010 Oct; 584(20):4313-8. PubMed ID: 20869963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA interference (RNAi) with RNase III-prepared siRNAs.
    Yang D; Goga A; Bishop JM
    Methods Mol Biol; 2004; 252():471-82. PubMed ID: 15017072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A
    J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA interference in vivo: toward synthetic small inhibitory RNA-based therapeutics.
    de Fougerolles A; Manoharan M; Meyers R; Vornlocher HP
    Methods Enzymol; 2005; 392():278-96. PubMed ID: 15644187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A structure-activity relationship study of siRNAs with structural variations.
    Chang CI; Hong SW; Kim S; Lee DK
    Biochem Biophys Res Commun; 2007 Aug; 359(4):997-1003. PubMed ID: 17577577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence-specific interference by small RNAs derived from adenovirus VAI RNA.
    Sano M; Kato Y; Taira K
    FEBS Lett; 2006 Mar; 580(6):1553-64. PubMed ID: 16472808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.